First Pharma Associates LLC dba Riverpoint Pharmacy
Form 483 issued March 3, 2021 · Spokane, Washington
- Inspection
- Feb 23 – Mar 3, 2021
- Investigators
- Christopher R. Czajka· Nathaniel B. Phillips-Sylvain
- Observations
- 1
- Pages
- 3
- FEI number
- 3007500366
In short: On March 3, 2021, FDA issued a Form 483 with 1 observation to First Pharma Associates LLC dba Riverpoint Pharmacy in Spokane, Washington (FEI 3007500366) after an inspection that ran Feb 23 – Mar 3, 2021. The investigators were Christopher R. Czajka and Nathaniel B. Phillips-Sylvain.
What FDA observed
Preview: the opening words of each observation- 01FDCA 501(a)(2)(A)
You produced highly potent chu gs without providing adequate cleaning of utensils…
This inspection in context
Christopher R. Czajka
37 documents · 2015–2025
Cites FDCA 501(a)(2)(A) (insanitary conditions) more than any other section. Most of their documents are for sites in California.
The firmFirst Pharma Associates LLC dba Riverpoint Pharmacy history
All 5 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at First Pharma Associates LLC dba Riverpoint Pharmacy?
FDA listed 1 observation on this Form 483. The opening words of each observation are shown on this page.
Who inspected First Pharma Associates LLC dba Riverpoint Pharmacy?
Christopher R. Czajka and Nathaniel B. Phillips-Sylvain are named on this Form 483, for the inspection of Feb 23 – Mar 3, 2021. Each investigator has a profile showing what they cite most.
When was First Pharma Associates LLC dba Riverpoint Pharmacy inspected by FDA?
The inspection ran Feb 23 – Mar 3, 2021, and the Form 483 is dated March 3, 2021.
How do I get the full Form 483 for First Pharma Associates LLC dba Riverpoint Pharmacy?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.